Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: Australia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20121
20171
20182
20205
20216
20223
20232
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Terminated5
Active, not recruiting4
Completed4
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
AbbVie (prior sponsor, Abbott)1
Aminex Therapeutics, Inc.1
Astellas Pharma Inc1
BioNTech SE1
Bristol-Myers Squibb1
Daiichi Sankyo1
ENB Therapeutics, Inc1
Eli Lilly and Company1
Filamon LTD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms29
Colorectal Neoplasms13
Endometrial Neoplasms13
Breast Neoplasms11
Carcinoma, Non-Small-Cell Lung9
Pancreatic Neoplasms9
Melanoma8
Stomach Neoplasms8
Prostatic Neoplasms7
Uterine Cervical Neoplasms7

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.